Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -684.31 Thousand | -10.94 Million | -13.73 Million | -8.85 Million | -11.13 Million | -9.77 Million |
| Net Income | -3.57 Million | -15.05 Million | -18.66 Million | -9.34 Million | -272.09 Thousand | -11.22 Million |
| Depreciation & Amortization | 1743.00 | 154.53 Thousand | 261.51 Thousand | 261.72 Thousand | 241.44 Thousand | 62.09 Thousand |
| Deferred income taxes | - | -730.44 Thousand | -6.31 Million | 1.14 Million | -4.57 Million | -1.43 Million |
| Stock-based compensation | - | 11.69 Thousand | 803.51 Thousand | 1.74 Million | 311.6 Thousand | 899.14 Thousand |
| Change in working capital | 3.73 Million | -590.94 Thousand | -5.07 Million | 3.6 Million | -3.62 Million | 534.85 Thousand |
| Other non-cash items | -842.67 Thousand | 5.26 Million | 15.25 Million | -6.25 Million | -3.21 Million | 1.38 Million |
| Investing Cash Flow | - | 123.51 Thousand | - | 225.23 Thousand | 337.81 Thousand | -3201.00 |
| Investments in PPE | - | 5.00 | - | - | -3000.00 | -6397.00 |
| Acquisitions | - | - | - | - | 340.81 Thousand | 3196.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 123.51 Thousand | - | - | - | - |
| Other Investing Activities | - | 123.51 Thousand | - | 225.23 Thousand | 340.81 Thousand | 3196.00 |
| Financing Cash Flow | - | -178.09 Thousand | 975.72 Thousand | 28.32 Million | 14.99 Million | 75 Thousand |
| Debt repayment | -2 Million | -178.09 Thousand | -229.14 Thousand | -244.82 Thousand | -4.11 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.52 Million | -785.68 Thousand | - |
| Common Stock Issuance | - | - | 1.2 Million | 28.56 Million | 10.22 Million | 75 Thousand |
| Other Financing Activities | -2 Million | -178.09 Thousand | -229.14 Thousand | 28.32 Million | 10.18 Million | 75 Thousand |
| Accounts receivables | 3.7 Million | -477.43 Thousand | 176.66 Thousand | -1.13 Million | -4.72 Million | -37.75 Thousand |
| Accounts payables | - | -1.07 Million | -4.33 Million | 4.34 Million | 767.48 Thousand | 600.15 Thousand |
| Inventory | - | 1.14 Million | -834.98 Thousand | 207.72 Thousand | 177.17 Thousand | 572.61 Thousand |
| Other working capital | 32.76 Thousand | -181.26 Thousand | -78.39 Thousand | 190.42 Thousand | 151.38 Thousand | -600.15 Thousand |
| Cash at beginning of period | 3 Million | 14.01 Million | 26.79 Million | 7.1 Million | 2.9 Million | 12.61 Million |
| Cash at end of period | 2.31 Million | 3 Million | 14.01 Million | 26.79 Million | 7.1 Million | 2.9 Million |
| Capital Expenditure | - | 5.00 | - | - | -3000.00 | -6397.00 |
| Effect of forex changes on cash | -4437.00 | -1066.00 | -27.31 Thousand | -3697.00 | - | - |
| Net cash flow / Change in cash | -688.74 Thousand | -11 Million | -12.78 Million | 19.69 Million | 4.19 Million | -9.7 Million |
| Free Cash Flow | -684.31 Thousand | -10.94 Million | -13.73 Million | -8.85 Million | -11.14 Million | -9.78 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.08 Million | -2.49 Million | -15.05 Million | -9.62 Million | -5.42 Million | -18.66 Million |
| Depreciation & Amortization | 867.00 | 876.00 | 154.53 Thousand | 11.04 Thousand | 143.49 Thousand | 261.51 Thousand |
| Deferred income taxes | - | - | -730.44 Thousand | -702.82 Thousand | - | -6.31 Million |
| Stock-based compensation | - | - | 11.69 Thousand | 11.69 Thousand | - | 803.51 Thousand |
| Change in working capital | 3.73 Million | - | -590.94 Thousand | 487.79 Thousand | - | -5.07 Million |
| Other non-cash items | -5.47 Million | 4.63 Million | 5.26 Million | 1.39 Million | 2.57 Million | 15.25 Million |
| Investing Cash Flow | - | - | 123.51 Thousand | 123.51 Thousand | 13.98 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 123.51 Thousand | - | - | - |
| Other Investing Activities | - | - | 123.51 Thousand | 123.51 Thousand | - | - |
| Financing Cash Flow | - | - | -178.09 Thousand | -19.74 Thousand | -158.34 Thousand | 975.72 Thousand |
| Debt repayment | - | - | -178.09 Thousand | - | -158.34 Thousand | -229.14 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.2 Million |
| Other Financing Activities | - | - | -178.09 Thousand | -19.74 Thousand | -158.34 Thousand | -229.14 Thousand |
| Accounts receivables | 3.7 Million | - | -477.43 Thousand | -477.43 Thousand | - | 176.66 Thousand |
| Accounts payables | - | - | -1.07 Million | - | - | -4.33 Million |
| Inventory | - | - | 1.14 Million | 1.14 Million | - | -834.98 Thousand |
| Other working capital | 32.76 Thousand | - | -181.26 Thousand | -181.26 Thousand | - | -78.39 Thousand |
| Cash at beginning of period | 5.15 Million | 3 Million | 14.01 Million | 11.12 Million | 14.01 Million | 26.79 Million |
| Cash at end of period | 2.32 Million | 5.15 Million | 3 Million | 3 Million | 11.12 Million | 14.01 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -14.22 Thousand | 9785.00 | -1066.00 | -3350.00 | 2284.00 | -27.31 Thousand |
| Net cash flow / Change in cash | -2.83 Million | 2.15 Million | -11 Million | -8.11 Million | -2.88 Million | -12.78 Million |
| Free Cash Flow | -2.82 Million | 2.13 Million | -10.94 Million | -8.24 Million | -2.7 Million | -13.73 Million |
3002
000320
2121
MEDICO
FPH
9034